Hologic
From Wikipedia, the free encyclopedia
Hologic | |
---|---|
Type | Medical Devices |
Founded | 1986 |
Headquarters | Bedford, Massachusetts, USA |
Key people | Founders: Former CEO and Chairman S. David Ellenbogen and Chief Technical Officer Jay A. Stein Ph.D |
Industry | Medical products |
Employees | 3000 |
Website | www.hologic.com |
Hologic (NASDAQ: HOLX) corporation is a leading developer, manufacturer and supplier of premium diagnostic and medical imaging systems dedicated to serving the healthcare needs of women, and a leading developer of state-of-the-art digital imaging technology for general radiography and mammography applications. It's core business units are focused on osteoporosis assessment, mammography and breast biopsy, direct-to-digital x-ray for general radiography applications and mini C-arm imaging for orthopedic applications. Its major brands include Lorad, Fluoroscan, Selenia, Securview, Discovery, Multicare and Directray.
Hologic is a leader in women's healthcare, particularly breast cancer diagnosis. [1]
Hologic is currencly developing tomosynthesis technology for breast cancer diagnosis. Hologic first demonstrated the technology at the Radiological Society of North America in November 2003. It provided patient images and a prototype add-on to its Selenia digital mammography system. Clinical trials for Hologic's tomosynthesis technology began in the summer of 2004. [2]
Hologic was the recipient of Frost and Sullivan's 2004 Technology Leadership of the Year Award in women's healthcare. [3]
[edit] Hologic/Cytyc Merger
On May 20, 2007, Hologic announced a merger (via a cash and stock transaction) with the Cytyc Corporation to create a $10 billion women's healthcare company with over $1 billion in projected annual sales.[4] The new company name will be "Hologic" and Cytyc will be a wholly-owned subsidiary. The combined corporation will deal in products for screening, diagnostics and therapy for breast and cervical cancer, menorrhagia, prenatal health, osteoporosis, endometriosis and permanent contraception.[5] The brands under the combined company include, ThinPrep(R), Lorad(R), NovaSure(R), Suros ATEC(R), Discovery(TM), FullTerm(R), R2(R) and MammoSite(R), and it will have operations in over twenty countries.[6] Patrick Sullivan, of Cytyc will be chairman of the new company, and Jack Cumming, of Hologic, will be Chief Executive Officer.[7] Cytyc shareholders will hold 55% of the firm, and Hologic will own 45%.
[edit] Footnotes
- ^ Hologic's Expensive Match-Up - Forbes.com
- ^ Hologic receives Frost & Sullivan's 2004 Technology Leadership of the Year Award in women's health diagnostics for breast cancer
- ^ Hologic receives Frost & Sullivan's 2004 Technology Leadership of the Year Award in women's health diagnostics for breast cancer
- ^ http://www.forbes.com/feeds/ap/2007/05/21/ap3740939.html
- ^ Hologic, Cytyc Merge | May 30, 2007 | CLPrime | Clinical Lab Products
- ^ http://news.corporate.findlaw.com/prnewswire/20070520/20may20071503.html
- ^ http://news.corporate.findlaw.com/prnewswire/20070520/20may20071503.html